Reflecting growing consensus that patient views should be incorporated into drug development and evaluation decisions, the Innovative Medicines Initiative is offering €12m ($13.14m) in funding for a project to explore the specifics of this concept.
The five-year project is expected establish recommendations that could help support development of guidance for industry, regulators and health technology...